FDA approves Novo Nordisk’s diabetes drug
Novo Nordisk A/S said the U.S. FDA approved on Monday its diabetes drug, Xultophy.The Danish drug maker said it planned to launch the drug...
Arog Pharmaceuticals Receives Orphan Drug Designation in the European Union for Crenolanib
Arog Pharmaceuticals, Inc , a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs to treat unmet medical needs...
ImmunoCellular Therapeutics reports Immune Monitoring Data from ICT-107 Phase 2 Trial in Newly Diagnosed Glioblastoma
ImmunoCellular Therapeutics, Ltd announced the presentation of updated immune monitoring data from the phase 2 trial of ICT-107 in patients with newly diagnosed glioblastoma....
Sanofi Receives FDA Approval of Soliqua 100/33 for the Treatment of Adults with Type 2 Diabetes
Sanofi announced that the U.S. FDA approved once-daily Soliqua 100/33 100 Units/mL & 33 mcg/mL for the treatment of adults with type 2 diabetes...
Sandoz’s Erelzi receives FDA Approval making it the First US Enbrel Biosimilar
Sandoz, a Novartis company, has announced its drug, Erelzi, has been approved by the FDA, in a significant development. ...
Teva Secures EU Approval of Trisenox for First Line Treatment of Low to Intermediate Risk Acute Promyelocytic Leukemia
Teva Pharmaceutical Industries Ltd announced it has obtained approval from the European Commission for an indication extension of Trisenox® (arsenic trioxide). This marks an...
PharmAkea Extends Collaboration with Celgene Corporation
PharmAkea Inc. announced the extension of their strategic collaboration with Celgene Corporation which was established to leverage PharmAkea's proprietary drug discovery platform and novel...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...